Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-07-15 HERSHBERG ROBERT Director Option exercise +2,000 $0.45 $900 2,000
2020-07-15 HERSHBERG ROBERT Director Sale −1,500 $43.60 $65K 500
2020-07-15 HERSHBERG ROBERT Director Sale −500 $44.58 $22K 0
2020-07-15 HERSHBERG ROBERT Director Option exercise · Stock Option (Right to Buy) −2,000 69,000
2020-07-09 RUBINSTEIN JULIE President Option exercise +15,275 $0.84 $13K 15,275
2020-07-09 RUBINSTEIN JULIE President Sale −15,275 $49.00 $748K 0
2020-07-09 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,275 94,725
2020-07-09 HILL NANCY LOUISE EVP, Operations & Program Mana Option exercise +17,400 $0.84 $15K 27,400
2020-07-09 HILL NANCY LOUISE EVP, Operations & Program Mana Sale −17,400 $49.00 $853K 10,000
2020-07-09 HILL NANCY LOUISE EVP, Operations & Program Mana Option exercise · Stock Option (Right to Buy) −17,400 100,600
2020-07-08 Cohen Chad M Chief Financial Officer Option exercise +30,000 $6.32 $190K 31,000
2020-07-08 Cohen Chad M Chief Financial Officer Sale −27,896 $46.82 $1.3M 3,104
2020-07-08 Cohen Chad M Chief Financial Officer Sale −2,104 $47.52 $100K 1,000
2020-07-08 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right To Buy) −30,000 640,000
2020-07-06 DOBMEIER ERIC Director Option exercise +10,000 $6.32 $63K 10,000
2020-07-06 DOBMEIER ERIC Director Sale −9,600 $47.34 $454K 400
2020-07-06 DOBMEIER ERIC Director Sale −400 $47.98 $19K 0
2020-07-06 DOBMEIER ERIC Director Option exercise · Stock Option (Right to Buy) −10,000 55,000
2020-07-06 BALDO LANCE Chief Medical Officer Option exercise +6,250 $7.80 $49K 6,250
2020-07-06 BALDO LANCE Chief Medical Officer Sale −6,050 $47.29 $286K 200

Page 98 of 120 · 2,386 trades